Welcome to our dedicated page for Univ Health Svc news (Ticker: UHS), a resource for investors and traders seeking the latest updates and insights on Univ Health Svc stock.
Universal Health Services, Inc. (UHS) is a New York Stock Exchange–listed hospital and healthcare services company that describes itself as one of the nation’s largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities, ambulatory centers and ambulatory care access points across the United States, Puerto Rico and the United Kingdom.
This news page for UHS stock aggregates company-specific announcements and media releases so readers can follow developments affecting the business and its shares. UHS regularly issues press releases on quarterly and year-to-date financial results, revisions to its full-year operating results forecast, dividend declarations and changes to its stock repurchase program authorization.
Investors can also find news about UHS’s participation in healthcare investor conferences, including presentations by senior executives, as well as announcements regarding earnings release dates and related conference calls and webcasts. The company’s communications often highlight operating trends in its acute care and behavioral health segments, liquidity and borrowing capacity under its revolving credit facility, and other financial and operational metrics.
In addition, UHS uses news releases to discuss corporate and governance matters, such as appointments to leadership roles and recognition in rankings like the Fortune 500, the Forbes Global 2000 and Fortune’s World’s Most Admired Companies. By reviewing the UHS news feed, readers can monitor financial updates, capital allocation decisions, facility-related developments and other events that the company identifies as important to shareholders and the broader market.
Universal Health Services, Inc. (UHS) reported a strong first quarter of 2023, achieving a net income of $163.1 million, or $2.28 per diluted share, up from $153.9 million or $2.02 per share in Q1 2022. Net revenues grew by 5.3% to $3.468 billion, compared to $3.293 billion in the prior year. Adjusted net income was $167.6 million, or $2.34 per diluted share, an increase from $163.5 million in the previous year. EBITDA also rose to $407.3 million from $368.3 million. Acute care services saw a 3.5% revenue increase, while behavioral health care services surged by 9.7%. However, net cash from operations decreased to $291 million from $445 million in 2022, primarily due to changes in working capital. The company has an available repurchase authorization of $869 million for its stock buyback program.
FAQ
What is the current stock price of Univ Health Svc (UHS)?
What is the market cap of Univ Health Svc (UHS)?
